Celltrion's autoimmune disease treatment gets approval in Europe
SEOUL, Feb. 24 (Yonhap) - Celltrion Inc., a major South Korean biopharmaceutical firm, said Monday its new biosimilar for an autoimmune disease treatment has o...
Publicado el: 2025-02-24 01:12:00
Autor: yna.co.kr, Fuente: yna.co.kr
Compartir: 
